# MUC2

## Overview
The MUC2 gene encodes mucin 2, a gel-forming glycoprotein that plays a critical role in the formation of the mucus barrier in the gastrointestinal tract. This protein is predominantly expressed in goblet cells of the intestinal epithelium and is essential for maintaining mucosal integrity by forming a protective gel-like layer that separates the epithelial surface from the gut lumen. Mucin 2 is characterized by its complex structure, which includes heavily glycosylated domains that facilitate its water-binding capacity and gel-forming properties, crucial for its function as a barrier against pathogens and mechanical damage (Van1995Mucin; Johansson2010The). The MUC2 gene's expression and the structural integrity of the mucin it encodes are vital for normal intestinal function, and alterations in MUC2 are associated with various gastrointestinal diseases, including inflammatory bowel disease and colorectal cancer (Gundamaraju2021Consequence; Van2006Muc2-Deficient).

## Structure
The MUC2 protein is a gel-forming mucin characterized by a complex molecular structure. Its primary structure includes a central region with variable number tandem repeats (VNTR) rich in serine, threonine, and proline residues, which are heavily O-glycosylated, contributing to the protein's large molecular mass and hydrophilic nature (Van1995Mucin; Gum1994Molecular). The VNTR region varies between 51 and 115 tandem repeats, providing a scaffold for extensive glycosylation (Van1995Mucin).

The secondary structure of MUC2 involves several domains, including von Willebrand factor-like D domains (D1, D2, D', D3) at the N-terminal and a cysteine knot (CK) domain at the C-terminal, which are crucial for polymerization (Yamashita2018Mucin; Stanforth2024The). The tertiary structure is stabilized by cysteine-rich regions forming disulfide bonds, which are essential for the protein's oligomerization and gel-forming properties (Gum1994Molecular; Seregni1997Structure).

In terms of quaternary structure, MUC2 monomers polymerize through disulfide bridges at the CK domain in the endoplasmic reticulum and trimerize at the D3 domains in the Golgi apparatus, forming disulfide-bound oligomers (Stanforth2024The; Van1995Mucin). These interactions contribute to the formation of a hydrated mucus gel, which is crucial for its protective function in the intestinal tract (Stanforth2024The).

## Function
The MUC2 gene encodes a gel-forming mucin that is a major component of the mucus layer in the gastrointestinal tract, particularly in the colon. This mucin is primarily expressed in goblet cells and plays a crucial role in maintaining the integrity of the epithelial barrier by forming a protective mucus layer that separates the intestinal epithelium from the gut lumen (Yamashita2018Mucin; Van2006Muc2-Deficient). MUC2 mucin is involved in the synthesis of secreted mucins, undergoing processes such as translation, folding, dimerization, and glycosylation, which are essential for its gel-forming properties (Corfield2001Mucins).

In healthy human cells, MUC2 forms two distinct mucus layers in the colon: an inner firm layer that is devoid of bacteria and an outer loose layer that harbors commensal bacteria. The inner layer acts as a physical barrier, preventing bacteria from contacting epithelial cells, thus protecting against inflammation and infection (Johansson2010The; Johansson2008The). The MUC2 mucin's structure, characterized by heavily glycosylated domains, contributes to its ability to bind water and form a viscoelastic gel, which is vital for its protective function (Johansson2010The; Corfield2001Mucins).

## Clinical Significance
Alterations in the MUC2 gene, which encodes the mucin 2 protein, are linked to several diseases, particularly inflammatory bowel disease (IBD) and colorectal cancer (CRC). In IBD, including ulcerative colitis (UC) and Crohn's disease (CD), changes in MUC2 expression and glycosylation patterns are observed. In UC, MUC2 mRNA expression is often decreased or unchanged, while protein levels can vary. In CD, the mucus layer thickness and total mucin levels are reduced, with MUC2 expression particularly decreased in the ileum. These alterations contribute to a compromised mucus barrier, increasing the risk of inflammation and disease pathology (Kang2022The).

In colorectal cancer, MUC2 expression is a significant marker. Mucinous adenocarcinomas, a subtype of CRC, are characterized by increased MUC2 expression, which is associated with a distinct molecular pathogenesis and resistance to chemotherapy. Conversely, non-mucinous adenocarcinomas often exhibit MUC2 deletion or underexpression, leading to chronic inflammation and tumor development. Loss of MUC2 expression is associated with disease recurrence and poor outcomes in CRC, while its presence correlates with longer survival, although its prognostic value remains debated (Gundamaraju2021Consequence; Elzagheid2012Loss).

## Interactions
MUC2, a major component of the intestinal mucus layers, interacts with several proteins, most notably the IgG Fc-binding protein (FCGBP). MUC2 is highly glycosylated and forms multimers, which complicates its purification and analysis. It is strongly bound to FCGBP through a covalent bond that is resistant to reduction and chaotropic salts. This interaction is mediated by the GDPH sequence in the von Willebrand D (vWD) domains of MUC2, which forms a reactive anhydride that covalently links the N-terminal part of FCGBP to other molecules (Johansson2009Proteomic).

In contrast, other studies suggest that MUC2 and FCGBP are non-covalently bound in secreted mucus, potentially through N-linked glycan-glycan interactions. This interaction is disrupted by tunicamycin, an N-linked glycosylation inhibitor, indicating the importance of glycosylation in their binding (Gorman2023IgGFcbinding). MUC2 also interacts with other mucins such as MUC12, MUC4, MUC16, MUC7, MUC1, and MUC17, as well as several polypeptide N-acetyl-galactosaminyltransferases associated with mucin glycosylation (Gorman2023IgGFcbinding). These interactions highlight the complex nature of mucin granules and the structural organization of the mucus barrier, with implications for innate immunity and host defense.


## References


[1. (Van1995Mucin) B. J. Van Klinken, J. Dekker, H. A. Buller, and A. W. Einerhand. Mucin gene structure and expression: protection vs. adhesion. American Journal of Physiology-Gastrointestinal and Liver Physiology, 269(5):G613–G627, November 1995. URL: http://dx.doi.org/10.1152/ajpgi.1995.269.5.G613, doi:10.1152/ajpgi.1995.269.5.g613. This article has 493 citations.](https://doi.org/10.1152/ajpgi.1995.269.5.G613)

[2. (Kang2022The) Youra Kang, Hyeonjeong Park, Byung-Ho Choe, and Ben Kang. The role and function of mucins and its relationship to inflammatory bowel disease. Frontiers in Medicine, May 2022. URL: http://dx.doi.org/10.3389/fmed.2022.848344, doi:10.3389/fmed.2022.848344. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmed.2022.848344)

[3. (Johansson2009Proteomic) Malin E. V. Johansson, Kristina A. Thomsson, and Gunnar C. Hansson. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the muc2 mucin, is strongly bound to the fcgbp protein. Journal of Proteome Research, 8(7):3549–3557, June 2009. URL: http://dx.doi.org/10.1021/pr9002504, doi:10.1021/pr9002504. This article has 184 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/pr9002504)

[4. (Gundamaraju2021Consequence) Rohit Gundamaraju and Wai Chin Chong. Consequence of distinctive expression of muc2 in colorectal cancers: how much is actually bad? Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1876(1):188579, August 2021. URL: http://dx.doi.org/10.1016/j.bbcan.2021.188579, doi:10.1016/j.bbcan.2021.188579. This article has 19 citations.](https://doi.org/10.1016/j.bbcan.2021.188579)

[5. (Stanforth2024The) Kyle J. Stanforth, Maria I. Zakhour, Peter I. Chater, Matthew D. Wilcox, Beth Adamson, Niamh A. Robson, and Jeffrey P. Pearson. The muc2 gene product: polymerisation and post-secretory organisation—current models. Polymers, 16(12):1663, June 2024. URL: http://dx.doi.org/10.3390/polym16121663, doi:10.3390/polym16121663. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/polym16121663)

[6. (Johansson2010The) Malin E. V. Johansson, Jessica M. Holmén Larsson, and Gunnar C. Hansson. The two mucus layers of colon are organized by the muc2 mucin, whereas the outer layer is a legislator of host–microbial interactions. Proceedings of the National Academy of Sciences, 108(supplement_1):4659–4665, June 2010. URL: http://dx.doi.org/10.1073/pnas.1006451107, doi:10.1073/pnas.1006451107. This article has 1037 citations.](https://doi.org/10.1073/pnas.1006451107)

[7. (Gum1994Molecular) J.R. Gum, J.W. Hicks, N.W. Toribara, B. Siddiki, and Y.S. Kim. Molecular cloning of human intestinal mucin (muc2) cdna. identification of the amino terminus and overall sequence similarity to prepro-von willebrand factor. Journal of Biological Chemistry, 269(4):2440–2446, January 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)41965-x, doi:10.1016/s0021-9258(17)41965-x. This article has 292 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)41965-x)

[8. (Corfield2001Mucins) P. Corfield, Anthony. Mucins in the gastrointestinal tract in health and disease. Frontiers in Bioscience, 6(1):d1321, 2001. URL: http://dx.doi.org/10.2741/corfield, doi:10.2741/corfield. This article has 180 citations and is from a peer-reviewed journal.](https://doi.org/10.2741/corfield)

[9. (Johansson2008The) Malin E. V. Johansson, Mia Phillipson, Joel Petersson, Anna Velcich, Lena Holm, and Gunnar C. Hansson. The inner of the two muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proceedings of the National Academy of Sciences, 105(39):15064–15069, September 2008. URL: http://dx.doi.org/10.1073/pnas.0803124105, doi:10.1073/pnas.0803124105. This article has 1554 citations.](https://doi.org/10.1073/pnas.0803124105)

[10. (Yamashita2018Mucin) Melissa Shizue de A. Yamashita and Eduardo O. Melo. Mucin 2 (muc2) promoter characterization: an overview. Cell and Tissue Research, 374(3):455–463, September 2018. URL: http://dx.doi.org/10.1007/s00441-018-2916-9, doi:10.1007/s00441-018-2916-9. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-018-2916-9)

[11. (Elzagheid2012Loss) Adam Elzagheid, Fatma Emaetig, Abdelbaset Buhmeida, Matti Laato, Omran El-Faitori, Kari Syrjänen, Yrjö Collan, and Seppo Pyrhönen. Loss of muc2 expression predicts disease recurrence and poor outcome in colorectal carcinoma. Tumor Biology, 34(2):621–628, November 2012. URL: http://dx.doi.org/10.1007/s13277-012-0588-8, doi:10.1007/s13277-012-0588-8. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13277-012-0588-8)

[12. (Van2006Muc2-Deficient) Maria Van der Sluis, Barbara A.E. De Koning, Adrianus C.J.M. De Bruijn, Anna Velcich, Jules P.P. Meijerink, Johannes B. Van Goudoever, Hans A. Büller, Jan Dekker, Isabelle Van Seuningen, Ingrid B. Renes, and Alexandra W.C. Einerhand. Muc2-deficient mice spontaneously develop colitis, indicating that muc2 is critical for colonic protection. Gastroenterology, 131(1):117–129, July 2006. URL: http://dx.doi.org/10.1053/j.gastro.2006.04.020, doi:10.1053/j.gastro.2006.04.020. This article has 1228 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2006.04.020)

[13. (Seregni1997Structure) Ettore Seregni, Carlo Botti, Simonetta Massaron, Claudia Lombardo, Alba Capobianco, Anna Bogni, and Emilio Bombardieri. Structure, function and gene expression of epithelial mucins. Tumori Journal, 83(3):625–632, May 1997. URL: http://dx.doi.org/10.1177/030089169708300301, doi:10.1177/030089169708300301. This article has 69 citations.](https://doi.org/10.1177/030089169708300301)

[14. (Gorman2023IgGFcbinding) Hayley Gorman, France Moreau, Antoine Dufour, and Kris Chadee. Iggfc-binding protein and muc2 mucin produced by colonic goblet-like cells spatially interact non-covalently and regulate wound healing. Frontiers in Immunology, June 2023. URL: http://dx.doi.org/10.3389/fimmu.2023.1211336, doi:10.3389/fimmu.2023.1211336. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1211336)